Valuation: Camurus AB

Market Cap 35.94B 3.64B 3.18B 3B 2.72B 5.11B 350B 5.13B 13.87B 178B 13.69B 13.39B 572B P/E 2026 *
35.8x
P/E 2027 * 25.5x
Enterprise Value 31.43B 3.19B 2.78B 2.62B 2.38B 4.46B 306B 4.48B 12.13B 155B 11.97B 11.7B 500B EV / Sales 2026 *
11x
EV / Sales 2027 * 8.04x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+2.98%
1 week+2.29%
Current month+3.51%
1 month-1.79%
3 months+13.32%
6 months+28.24%
Current year-1.95%
1 week 574.5
Extreme 574.5
610.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
714.5
3 years 293
Extreme 293
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 A Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 A Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 A Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+2.98%+2.29%-12.46%+107.99% 3.55B
+0.04%+2.67%+51.68%+100.28% 1,027B
-0.09%+1.37%+52.36%+67.23% 651B
-0.02%+3.51%+19.54%+73.52% 467B
-1.22%+3.27%+37.02%+36.52% 350B
-0.79%+2.64%+19.18%+24.76% 268B
+0.58%+6.31%+9.69%+14.26% 257B
+1.55%+0.83%+40.38%+47.92% 205B
+0.79%-1.66%-23.80%-57.76% 190B
-0.52%+3.66%+33.72%+98.37% 187B
Average +0.56%+2.17%+22.73%+51.31% 360.57B
Weighted average by Cap. +0.20%+2.62%+35.20%+61.53%

Financials

2026 *2027 *
Net sales 2.86B 290M 253M 238M 217M 406M 27.79B 407M 1.1B 14.13B 1.09B 1.06B 45.46B 3.75B 380M 331M 313M 284M 532M 36.46B 535M 1.45B 18.54B 1.43B 1.4B 59.65B
Net income 978M 99.13M 86.44M 81.62M 74.12M 139M 9.51B 139M 377M 4.84B 372M 364M 15.56B 1.37B 139M 121M 115M 104M 195M 13.35B 196M 529M 6.79B 523M 511M 21.83B
Net Debt -4.52B -458M -399M -377M -342M -642M -43.95B -644M -1.74B -22.34B -1.72B -1.68B -71.89B -5.81B -589M -513M -485M -440M -825M -56.5B -828M -2.24B -28.72B -2.21B -2.16B -92.42B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
18/09/26 SEK 604.00 +2.98% 204,289
17/09/26 SEK 586.50 +1.65% 43,094
16/09/26 SEK 577.00 -3.19% 112,612
15/09/26 SEK 596.00 +0.34% 55,736
14/09/26 SEK 594.00 +1.71% 48,699
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
604.00SEK
Average target price
793.00SEK
Spread / Average Target
+31.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!